MannKind Corporation Reports 2016 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Doubles MannKind (MNKD) PT to 10 Cents
May 10, 2016 6:48 AM EDTPiper Jaffray analyst Joshua Schimmer doubled his price target on MannKind (NASDAQ: MNKD) to $0.10 (from $0.05) following Q1 results and its updated cash burn. The firm maintained an Underweight rating on the stock.
Schimmer commented, "After the close MNKD reported 1Q16 results... More
MannKind (MNKD) Misses Q1 EPS by 2c
May 9, 2016 4:01 PM EDTMannKind (NASDAQ: MNKD) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04).
The Companys portion of the loss sharing under the Sanofi License Agreement was $5.5 million for the first quarter of 2016. The total amount owed to Sanofi is currently $68.8 million, including... More
